HomeUSMLE Step 1Genetics

Master Genetics
for USMLE Step 1

Access 30+ high-yield questions tailored for the 2026 syllabus. Includes AI-powered explanations and performance tracking.

Start Free Practice View Full Syllabus
HIGH YIELD NOTES ~5 min read

Core Concepts

Core genetics for USMLE Step 1 covers molecular processes, inheritance patterns, chromosomal disorders, and population genetics. Focus on high-yield examples and diagnostic principles.

  • Molecular Basics:
    • DNA/RNA: Replication, Transcription, Translation. Key enzymes: DNA/RNA pol, helicase, ligase.
    • Mutations: Point (silent, missense, nonsense), Frameshift (indel not mult of 3), Splice site.
    • Trinucleotide Repeats: Expansion causes anticipation. Ex: Huntington (CAG), Myotonic Dystrophy (CTG), Fragile X (CGG), Friedreich Ataxia (GAA).
  • Mendelian Inheritance:
    • Autosomal Dominant (AD): Vertical transmission, 50% risk, male-to-male. Ex: Huntington, Marfan, Neurofibromatosis 1.
    • Autosomal Recessive (AR): Horizontal, 25% risk (carrier parents), skipped generations, consanguinity. Ex: Cystic Fibrosis, Sickle Cell, PKU.
    • X-Linked Dominant (XD): No male-to-male. Fathers to all daughters. Ex: Fragile X (some presentations), Rett.
    • X-Linked Recessive (XR): No male-to-male. Sons of carrier mothers 50%. Males more affected. Ex: Hemophilia, Duchenne Muscular Dystrophy, G6PD deficiency.
    • Mitochondrial: Maternal inheritance (all children), heteroplasmy. Ex: Leber hereditary optic neuropathy (LHON), MELAS.
  • Non-Mendelian Inheritance:
    • Genomic Imprinting: Gene expression based on parental origin (methylation). Ex: Prader-Willi (paternal deletion/maternal UPD), Angelman (maternal deletion/paternal UPD).
    • Mosaicism: Presence of genetically distinct cell lines within an individual.
    • Heterogeneity: Locus (different genes, same phenotype), Allelic (different mutations same gene, same phenotype).
  • Chromosomal Abnormalities:
    • Aneuploidy:
      • Trisomy 21 (Down): ID, epicanthal folds, single palmar crease, cardiac defects.
      • Trisomy 18 (Edwards): Severe ID, micrognathia, clenched hands.
      • Trisomy 13 (Patau): Cleft lip/palate, polydactyly.
      • Turner (45, XO): Short stature, webbed neck, coarctation of aorta, primary amenorrhea.
      • Klinefelter (47, XXY): Tall stature, gynecomastia, small testes.
    • Structural: Deletions (DiGeorge 22q11 deletion), Translocations (Robertsonian).
  • Hardy-Weinberg Principle: p^2 + 2pq + q^2 = 1 (genotype freq); p + q = 1 (allele freq). Assumes: no mutation, no migration, no selection, random mating, large population.

Clinical Presentation

  • Highly variable, often multisystemic.
  • Developmental delay, intellectual disability, dysmorphic features.
  • Specific organ dysfunction (e.g., cardiac, renal, neurological).
  • Metabolic crises (inborn errors of metabolism), cancer predisposition. Family history is key.

Diagnosis (Gold Standard)

  • Karyotyping: For gross chromosomal abnormalities (aneuploidy, large translocations).
  • FISH (Fluorescence In Situ Hybridization): For targeted microdeletions/duplications (e.g., DiGeorge, Prader-Willi).
  • Array CGH (Comparative Genomic Hybridization): Genome-wide detection of copy number variants (deletions/duplications).
  • PCR-based Methods: For trinucleotide repeats, specific point mutations.
  • Sanger Sequencing: Gold standard for specific gene sequencing (point mutations, small indels).
  • Next-Generation Sequencing (NGS) (Exome/Genome): High-throughput for panels, exomes, or whole genomes, especially for heterogeneous or unknown causes.
  • Biochemical Assays: For inborn errors of metabolism (enzyme activity, metabolite levels).
  • Prenatal: Amniocentesis, Chorionic Villus Sampling (CVS), Non-Invasive Prenatal Screening (NIPS).

Management (First Line)

  • Supportive Care: Symptom management, rehabilitation, nutritional adjustments (e.g., PKU diet).
  • Enzyme Replacement Therapy (ERT): For specific lysosomal storage diseases (e.g., Gaucher disease).
  • Pharmacological Interventions: Targeted therapies for specific molecular defects (e.g., CFTR modulators for Cystic Fibrosis).
  • Genetic Counseling: Essential for risk assessment, family planning, and education.
  • Surveillance: Regular monitoring for associated complications (e.g., cancer screening).
  • Gene Therapy: Emerging field for specific conditions (e.g., Spinal Muscular Atrophy).

Exam Red Flags

  • Quickly interpret pedigrees for AD, AR, XD, XR. Remember no male-to-male transmission for X-linked disorders.
  • Distinguish Genomic Imprinting (parental origin-specific expression) from simple deletion or Uniparental Disomy. Prader-Willi is paternal, Angelman is maternal.
  • Associate common chromosomal disorders (Down, Turner, Klinefelter, DiGeorge) with their classic clinical features and genetic basis.
  • Anticipation in a pedigree always points to trinucleotide repeat expansion disorders (e.g., Huntington, Fragile X).
  • Understand and apply Hardy-Weinberg equilibrium assumptions and calculations for allele/genotype frequencies.
  • Match diagnostic tests (Karyotyping, FISH, Array CGH, Sanger, NGS) to the appropriate size and type of genetic abnormality they detect.

Sample Practice Questions

Question 1

A 3-day-old male newborn presents with abdominal distension and failure to pass meconium. Physical examination reveals a palpable, doughy mass in the right lower quadrant. His older sibling had similar issues and was diagnosed with a genetic condition characterized by recurrent respiratory infections and malabsorption, requiring pancreatic enzyme supplementation. A sweat chloride test on the newborn is pending but expected to be elevated. Both parents are healthy and deny any history of the condition themselves.

A) Autosomal dominant
B) Autosomal recessive
C) X-linked recessive
D) Mitochondrial inheritance
Explanation: This area is hidden for preview users.
Question 2

A 4-year-old girl is diagnosed with cystic fibrosis after presenting with recurrent respiratory infections and steatorrhea. Genetic testing confirms homozygous F508del mutations. Her parents are concerned about the long-term management and potential complications. Beyond respiratory and nutritional support, which of the following is an essential long-term screening measure for this patient?

A) Regular echocardiograms for pulmonary hypertension
B) Annual liver biopsy for primary sclerosing cholangitis
C) Screening for diabetes mellitus
D) Electromyography for peripheral neuropathy
Explanation: This area is hidden for preview users.
Question 3

A 48-year-old man presents with progressive choreiform movements and significant cognitive decline. His father developed similar symptoms at age 62, and his paternal grandfather had onset in his late 70s. The patient's 20-year-old daughter is considering genetic testing due to her family history and is concerned about developing symptoms at an even younger age.

A) Variable expressivity
B) Incomplete penetrance
C) Genetic anticipation
D) Pleiotropy
Explanation: This area is hidden for preview users.

Ready to see the answers?

Unlock All Answers

USMLE Step 1

  • ✓ 30+ Genetics Questions
  • ✓ AI Tutor Assistance
  • ✓ Detailed Explanations
  • ✓ Performance Analytics
Get Full Access